Liraglutide for Diabetes: Evidence and Outcomes

View Evidence Brief

Evidence on outcomes studied for Liraglutide

Evidence related to liraglutide and liraglutide-containing intervention regimens in diabetes studies.

Build your Evidence Workspace

Save evidence about the topics you care about.

Studies

Evidence Pairs

Moderate Evidence

Evidence Strength: 61/100

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Liraglutide evidence appears to center on Body weight.

Among 16 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. Body weight appears to be one of the clearer current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Body weight appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 7 evidence pairs - 9 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsModerate evidence

Body weight

7 studies

EvidenceScore™

83/100

ConsistencyScore™

83/100

HbA1c

4 studies

EvidenceScore™

79/100

ConsistencyScore™

70/100

Evidence Snapshot

Studies

Interventions

Outcomes

Strong evidence signals

Mixed evidence areas

Key Findings

Key patterns and insights identified across the research landscape

Moderate positive signal

Body weight

Across 6 studies, Liraglutide shows a consistent moderate positive signal for Body weight.

6 studies

EvidenceScore™: 82.91025641025641/100

View supporting studies

Moderate positive signal

HbA1c

Across 4 studies, Liraglutide shows a consistent moderate positive signal for HbA1c.

4 studies

EvidenceScore™: 79/100

View supporting studies

Moderate positive signal

BMI

Across 3 studies, Liraglutide shows a consistent moderate positive signal for BMI.

3 studies

EvidenceScore™: 75.92307692307692/100

View supporting studies

Neutral signal

Adverse events incidence

Across 2 studies, Liraglutide shows a neutral signal for Adverse events incidence.

2 studies

EvidenceScore™: 69/100

View supporting studies

Evidence signal

Gastrointestinal disorders incidence

Across 2 studies, Liraglutide shows a evidence signal for Gastrointestinal disorders incidence.

2 studies

EvidenceScore™: 69/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Body weight is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Body weight

HbA1c

Body weight

7 studies

EvidenceScore™

83/100

ConsistencyScore™

83/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present

Evidence basis: 6 evidence pairs - 10 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

HbA1c may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

HbA1c

BMI

HbA1c

4 studies

EvidenceScore™

79/100

ConsistencyScore™

70/100

Why this appears here

Positive effect signalLimited study volume

Evidence basis: 6 evidence pairs - 9 studies

View supporting studies

Question Highlights

Quick answers to the most important questions supported by the available evidence.

Explore all evidence questions

What outcomes has Liraglutide been studied for?

Body weight, HbA1c, and BMI are among the most studied areas in relation to Liraglutide.

Body weight, HbA1c, and BMI are among the best-supported options in the available evidence across 16 studies.

Consistency cannot yet be determined.

View full answer

Does Liraglutide affect body weight?

Liraglutide may improve Body weight.

Strong evidence is based on 7 supporting studies.

Population details are unavailable.

View full answer

How does Liraglutide compare across studied outcomes?

Body weight, HbA1c, and BMI have available evidence for Liraglutide, but the comparison requires review of the underlying studies.

Evidence is available for both BMI and Body weight; the underlying studies are needed for a direct comparison.

Population details are unavailable.

View full answer

Explore all evidence questions

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Questions Answered by the Evidence

What outcomes has Liraglutide been studied for?

outcomes studied

Emerging Evidence

Body weight, HbA1c, and BMI are among the most studied areas in relation to Liraglutide.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Body weight
EvidenceScore™ Strong | EvidenceScore™ 82.9 | moderate positive | ConsistencyScore™ Consistent | 7 studies
2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 4 studies
3
BMI
EvidenceScore™ Strong | EvidenceScore™ 75.9 | moderate positive | ConsistencyScore™ Consistent | 4 studies

Why this answer: This answer is based on 16 supporting studies and existing graph evidence signals.

Limitations

Consistency cannot yet be determined.
Population details are unavailable.

Does Liraglutide improve HbA1c?

intervention outcome_effect

Strong Evidence

Liraglutide may improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 4 studies

Why this answer: This answer is based on 4 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Does Liraglutide affect body weight?

intervention outcome_effect

Strong Evidence

Liraglutide may improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Body weight
EvidenceScore™ Strong | EvidenceScore™ 82.9 | moderate positive | ConsistencyScore™ Consistent | 7 studies

Why this answer: This answer is based on 7 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Which outcomes have the strongest evidence for Liraglutide?

evidence strength

Strong Evidence

Body weight, HbA1c, and BMI have the strongest available evidence signals for Liraglutide.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Body weight
EvidenceScore™ Strong | EvidenceScore™ 82.9 | moderate positive | ConsistencyScore™ Consistent | 7 studies
2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 4 studies
3
BMI
EvidenceScore™ Strong | EvidenceScore™ 75.9 | moderate positive | ConsistencyScore™ Consistent | 4 studies

Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Where does Liraglutide need more research?

research gaps

Moderate Evidence

Waist circumference, Systolic blood pressure, and Adverse events incidence need more research in relation to Liraglutide.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
Systolic blood pressure
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies
2
Waist circumference
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Consistent | 2 studies
3
Glucose iAUC (OGTT)
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

How does Liraglutide compare across studied outcomes?

cross outcome_comparison

Strong Evidence

Body weight, HbA1c, and BMI have available evidence for Liraglutide, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Body weight
EvidenceScore™ Strong | EvidenceScore™ 82.9 | moderate positive | ConsistencyScore™ Consistent | 7 studies
2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 4 studies
3
BMI
EvidenceScore™ Strong | EvidenceScore™ 75.9 | moderate positive | ConsistencyScore™ Consistent | 4 studies

Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Evidence summary for AI and search

Among 16 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. Body weight appears to be one of the clearer current evidence signals.